Indivior Faces Major Setback: Revenue and Profit Forecasts Dipped

Indivior Faces Major Setback: Revenue and Profit Forecasts Dipped
1 month ago

Indivior, a pharmaceutical company renowned for its critical role in combating opioid addiction through its Suboxone film product, has recently experienced a significant downturn in its stock value following alarming forecasts regarding its revenue and profit. On February 20, 2025, the company announced its expectations for a decline in earnings over the next year, resulting in a staggering 35% drop in share prices during intraday trading.

Continue reading
Indivior Secures Financial Stability with Debt Refinancing Deal

Indivior Secures Financial Stability with Debt Refinancing Deal
5 months ago

Indivior, the global pharmaceutical company known for its treatments for addiction and mental health disorders, has successfully extended the maturity of its debt through a strategic refinancing of its term loan. This maneuver is aimed at enhancing the company's financial flexibility and overall stability as it navigates the post-pandemic recovery landscape.

Continue reading